Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia

Early results of the fludarabine, cyclophosphamide, and rituximab (FCR) regimen in 224 patients showed that it was highly active as initial therapy of chronic lymphocytic leukemia. In this report, we present the final results of all 300 study patients at a median follow up of 6 years. The overall re...

Full description

Saved in:
Bibliographic Details
Main Authors: Tam, Constantine S., O'Brien, Susan, Wierda, William, Kantarjian, Hagop, Wen, Sijin, Do, Kim-Anh, Thomas, Deborah A., Cortes, Jorge, Lerner, Susan, Keating, Michael J.
Format: Artigo
Language:Inglês
Published: American Society of Hematology 2008
Subjects:
Clinical Trials and Observations
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3952498/
https://ncbi.nlm.nih.gov/pubmed/18411418
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2008-02-140582
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items